SEC Form 4 · accession 0001179110-16-019956
Theravance Biopharma, Inc. · TBPH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Frank Pasqualone
Officer — Sr. VP, Operations
Period of report
Feb 20, 2016
Accepted (ET)
Feb 23, 2016 · 7:55 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001583107
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary SharesF1 | Feb 20, 2016 | F | 10,830 | $15.65 | D | 127,178 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Includes 1,400 shares acquired under the Theravance Biopharma, Inc. 2013 Employee Share Purchase Plan on May 15, 2015 and 894 shares acquired under the Theravance Biopharma, Inc. 2013 Employee Share Purchase Plan on November 13, 2015.